FDA Inspection
Glenmark Pharmaceuticals LimitedGlenmark Pharmaceuticals Limited – FDA Inspection, May 29, 2015
Record Details
This FDA Inspection record concerns Glenmark Pharmaceuticals Limited, with an inspection on May 29, 2015, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- May 29, 2015
- Product Type
- Drugs
View Company Profile
ID · e5a82147-ec6f-492c-83d4-281cf15f8b12
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 929619
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Glenmark Pharmaceuticals Limited
7| Date | Classification | Office | Project area |
|---|---|---|---|
| June 22, 2022 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 20, 2019 | Not classified | Office of Inspections and Investigations | Drug Quality Assurance |
| September 21, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 11, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 19, 2017 | Not classified | Office of Inspections and Investigations |
Other documents for Glenmark Pharmaceuticals Limited
- FDA Inspection 1172425 - 2022-06-22
- FDA Inspection 1087639 - 2019-04-20
- FDA Inspection 1070594 - 2018-09-21
- FDA Inspection 1031652 - 2017-11-11
- FDA Inspection 1012923 - 2017-04-19
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.